13F-HR/A filed by Artia Global Partners LP
Artia Global Partners LP filed this 13F-HR/A for the quarter ended 2025-09-30, filed 2025-11-14, with 51 holding rows worth $630,889,037.
- Accession
- 0001937964-25-000009
- Filer
- CIK 1937964
- Filed
- 2025-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, amendment of type restatement, 51 entries on the cover page, a total value of $630,889,037 stated on the cover page (in dollars after the unit check, H1), rows summing to $630,889,037 with VALUE read as dollars as filed, 13F file number 028-23071. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INSMED INC COM PAR $.01 | 457669307 | Stock | 732,212 | $105,445,850 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 78,311 | $57,759,061 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 400,000 | $57,604,000 | dollars as filed | call |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 672,176 | $45,439,098 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 379,004 | $40,443,517 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 658,839 | $38,456,432 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 296,750 | $27,939,013 | dollars as filed | |
| PROSHARES TR II | 74347W601 | ULTRA GOLD | 537,372 | $24,751,354 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 28,700 | $21,898,100 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 55,100 | $21,579,364 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 225,453 | $19,140,960 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,999,702 | $18,297,273 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 183,200 | $17,885,816 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 34,570 | $15,763,920 | dollars as filed | |
| QUEST DIAGNOSTICS INC COM | 74834L100 | Stock | 81,717 | $15,573,626 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 190,752 | $14,634,493 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 628,367 | $8,947,946 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 10,671 | $5,999,983 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 194,838 | $5,541,193 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 104,190 | $4,865,673 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 110,100 | $4,797,057 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 150,000 | $4,512,000 | dollars as filed | call |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 108,723 | $4,278,250 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 60,176 | $3,936,714 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 146,179 | $3,841,584 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 96,285 | $3,585,653 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 14,500 | $3,357,330 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 57,999 | $3,300,143 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 133,291 | $3,232,307 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 12,240 | $2,433,434 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 56,600 | $2,146,272 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 5,000 | $2,096,050 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 54,515 | $1,969,354 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 64,502 | $1,940,220 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 64,608 | $1,918,858 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 141,061 | $1,649,003 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 40,000 | $1,606,000 | dollars as filed | |
| IRENLTDF | Q4982L109 | STOK | 33,200 | $1,558,076 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 22,951 | $1,524,635 | dollars as filed | |
| BRIGHTSPRING HEALTH SVCS | 10950A106 | COM | 41,600 | $1,229,696 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 80,000 | $1,200,800 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 29,200 | $1,133,836 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 20,400 | $1,059,576 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 475,361 | $979,244 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 44,900 | $865,223 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 30,900 | $738,510 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 23,800 | $614,754 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 41,555 | $506,140 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 600,000 | $432,840 | dollars as filed | call |
| ATYR PHARMA INC | 002120202 | COM NEW | 372,276 | $268,560 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 71,029 | $210,246 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001937964-25-000008 | superseded | 2025-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001937964-25-000009 | this filing | 2025-11-14 | acceptance time not in the bulk data set |